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Summary: Plasma and erythrocyte Mg24" concentrations were found to be increased in 14 haemodialysis patients
with chronic renal failure and in 7 chronic renal failure patients receiving chronic ambulatory peritoneal dialysis.
The rate of Na+TMg2* antiport was significantly higher in haemodialysis patients, but not in chronic ambulatory
peritoneal dialysis patients (control: 0.15 ± 0.02, haemodialysis: 0.46 ± 0.08, chronic ambulatory peritoneal dialy-
sis: 0.21 ± 0.06; Mg2"1", mmol/30 min X l cells). High erythrocyte Mg2+ content in chronic renal failure results
from the increased plasma Mg2+, which induces elevated Mg2"1" uptake during haematopoiesis. An increased rate
of Na+/Mg2+ antiport, which only performs Mg2+ efflux, leads to a relatively lower erythrocyte Mg2+ content in
haemodialysis patients compared with chronic ambulatory peritoneal dialysis patients. The elevated Na+/Mg24"
antäport in erythrocytes from haemodialysis patients was almost normalised after haemodialysis.
Incubation of normal erythrocytes with heat-inactivated plasma from haemodialysis patients led to a doubling of
Na+/Mg2+ antiport, indicating the presence of a heat-stable, dialysable plasma factor. This factor does not accumu-
late in chronic ambulatory peritoneal dialysis patients. After renal transplantation all changed quantities of Mg24"
metabolism returned to normal.
Introduction take up Mg2+ when incubated at increased extracellular
Mg2"1" concentration (6). On the other band, uraemic
In patients with chronic renal failure, the plasma Mg2+ plasma may a,ter Mg2+ flux across the erythrocyte
concentration is increased due to reduced renal excre- membrane. In human erythrocytes, net Mg2+ efflux has
tion, and the Mg?+ content of erythrocytes is higher than been characterised äs Na^/Mg24" antiport (7). Therefore,
in healthy cöntrols (1)· In addition, Inhibition of Na+/ we tested Na+/Mg2+ antiport in erythrocytes from
Li+ antiport (2), activatipn öf Na+/H+ antiport (3), and chronic renal failure patients and in erythrocytes after
increased concentration of Na"1" and Ca24" (4) were found renai transplantation, and investigated the effect of urae-
in erythrocytes of uraemic patients. The elevated Ca2* mic plasma on the net Mg24" efflux and influx of normal
content is caused by reduced aetivity of the Ca2+-pump- erythrocytes.
ing ATPase, caused by ä substance circulating in urae-
mic plasma (5). The inechanism of the increase of the
erythroeyte Mg?+ content is not known. It may be Methods
caused by increased Mg24" influx and/or decreased Patients
Mg2+ effllax. The Mg2"1" uptake may increase during Twenty one patients with chronic renal failure (Hon haemodialy-
erythropoiesis äs a consequence of the increased plasma *is and 7 on chronic ambulatory peritoneal dialysis treatment) were
~ . ' . . . studied (tab. 1). In haemodialysis patients, an extracorporeaU
Mg2+ concentration, since only haematopoietic precur- pump.assisted circulation of blood (200 ml/min during tbur hours
sor cells and reticuloeytes but not mature erythrocytes three times a week) is exposed to dialysis solution (Hospal 252%
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reraoval of the ionophore, the cells were incubated four times in
KC1 medium plus 10 g/l bovine serum albumin for 10 min at 37 °C.
The KC1 medium was removed by washing the cells twice with
cold (4 °C) cholinium chloride medium (in nimol/1: 140 cholinium
Chloride, 5 glucose, 30 Hepes/Tris, pH 7.4). This loading procedure
raised the intracellular Mg2+ concentration to about 20 mmol/1
cells. Mg2"1" efflux was measured by reincubating a cell Suspension
(cell volume fraction 0.1) at 37 °C üY Mg2+-free NaCl medium
(Substitution of KC1 in KC1 medium by 140 mmol/1 NaCl) and
Mg2+-free cholinium chloride medium. At the beginning of reincu-
bation and after 30 min, 0.5 ml aliquots of the cell suspensions
were centrifuged for l min at 10000g. Aliquots (100 ) of the
supernatants were diluted with l ml 100 g/l trichloroacetic acid/
1.75 g/l LaCl3, and Mg2"1" was measured by AAS. Mg2+ efflux was
calculated from the increase of Mg2+ in the reincubation media
and was expressed in relation to cell volume. Cell Volume was
determined by measuring the haematocrit. Na+-dependent Mg2+
efflux (Na+/Mg2+ antiport) was determined by subtracting the
Mg2+ efflux in cholinium chloride medium from the Mg2+ efflux
in Na+ medium. Additionally, erythrocytes from a control were
incubated for 18 h with heaMnactivated (30 min, 56 °C), uraemic
plasma from four haemodialysis patients or with heat-inactivated
homologous plasma. Thereafter, the cells were loaded with Mg2+
and Na+/Mg2+ antiport was measured.
Hospal Medizintechnik GmbH, Nürnberg, Germany, [Mg2+] = 0.5
mmol/1). This treatment removes toxic materials and solute by dif-
fiision and ultra filtration through a high-flux, polysulfon haemodi-
alyser. Blood was collected at the end of haemodialysis. In chronic
ambulatory peritoneal dialysis 1.5 liters of a dialysis solution (Fre-
senius CAPD Standard Lösung, Fresenius AG, Bad Homburg, Ger-
many, [Mg2"1"] = 0.5 mmol/1) are introduced four or five times ev-
ery day into the peritoneal cavity. Toxic material and solute is con-
tinuously eliminated by diffusion and ultra filtration via the mem-
brane of the peritoneum. All the patients with chronic renal failure
had received haemodialysis or chronic ambulatory peritoneal dialy-
sis treatment for more than 6 months.
For a better discrimination between the effect of renal disease and
artificial, e. g. mechanical effects of haemodialysis, blood samples
were taken from some patients (n = 4) before and after haemodia-
lysis treatment. Furthermore, 10 former chronic renal failure pa-
tients, who had received renal transplantation more than one year
previously, with subsequent good graft function (serum creatinine
concentration < 200 umol/1), were included. All transplanted pa-
tients were treated with cyclosporin. As controls, blood samples
from 11 healthy subjects were analysed.
Plasma and erythrocyte Mg2"1"
Blood was heparinized and centrifuged for 10 min at 1000g.
Plasma was withdrawn and used for the measurement of Mg2"1" and
Ca2+ by atomic absorption spectrophotometry (AAS, Philips SP9)
after appropriate dilution with 100 g/l trichloroacetic acid/1.75 g/l
LaCl3. Part of the erythrocytes was taken for the measurement of
the intracellular Mg2+ content. For this purpose, the erythrocytes
were washed twice in 150 mmol/1 NaCl, deproteinized with 100
g/l trichloroacetic acid/1.75 g/l LaCl3, centrifuged, and the Mg2"4"
content of the trichloroacetic acid extract measured by AAS. The
Mg2+ content was related to cell volume, determined from the
haematocrit.
Na+/Mg2+ antiport
Another part of the washed erythrocytes was used for measurement
of Mg2+ efflux, äs already described (8). Briefly, the cells wete
loaded with Mg2+ by incubating a cell Suspension (cell volume
fraction 0.1) for 30 min at 37 °C in KC1 medium (in mmol/1: 140
KC1,12 MgCl2, 50 sucrose, 5 glucose, 30 Hepes/Tris, pH 7.4) with
the addition of 6 / of the cation ionophore A23187 (Boell··
ringer Mannheim, Germany) dissolved in dimethyl sulphoxide. For
Mg2+ uptake
Erythrocytes from a control were incubated with heat-inactivated
(30 min, 56 °C), üraemic plasma from seven haemodialysis pa-
tients, and with heat-inactivated homologous plasma (haematocrit:
0.50) for l, 3, 5 and 24h at 37 °C. The same ineubations were
performed with the addition of 3 rnmol/1 MgCl2. At the end of
ineubations, cells were washed twice with 150 mmol/1 NaCl and
the cellular Mg2+ content was determined äs described above.
Results
Mg2+ concentrations in plasma and erythrocytes were
significantly increased in chronic renal failure patients
receiving haemodialysis and chronic ambulatory perito-
neal dialysis, thus confirming published data (l, 4). In
renal transplant recipients, the Mg2+ content in plasma
and erythrocytes was within the normal ränge, but lower
than in controls (tab. 2).
Mg2+ contents and rates of Na+/Mg2+ antiport in eryth-
rocytes of controls (tab. 2) were within the same ränge
äs reported in previous studies (9). However, Na+TMg2*
antiport was elevated in haemodialysis patients, the
mean value being three times that of controls. In chronic
ambulatory peritoneal dialysis patients, Na+/Mg?+ anti-
port was not significantly increased. With high Mg2+
loading (20 mmol/1 cells), the values represent the Vm3ai
of Na+TMg2"*· antiport. The increase in Na+TMg2* anti-
port in haemodialysis patients was reversible; imrriedi-
ately after dialysis it was significantly reduced (tab. 3)
but not normalised.
After renal transplantation, the erythrocyte Mg2"1" con-
centration and the rate of Na^/Mg24" antiport were not
significamtly different from those in healthy controls
(tab. 2). * l
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Tab. 2 Plasma and erylhrocyte [Mg2*] and erythrocytc Na*/
Mg2* antiport activity in chronic renal failure patients and renal
transplant recipients. Mean ± SEM. Least significant difference to
controls according to single factor analysis of variance; *,
p < 0.05; ***, p < 0.001.
Control
Haemodialysis patients




























Tab. 3 Plasma [Mg2*] and erythrocyte [Mg2*] and Na*/Mg2*
antiport activity in haemodialysis patients (n = 4) before and im-
mediately after haemodialysis. Significant differences according to
paired Student^ t-test; *, p < 0.05; **, p < 0.01.
Before haemodialysis After haemodialysis
Mg2* plasma (mmol/1)
Mg2* erythrocytes (mmol/1 cells)







When normal erythrocytes were incubated for 18h at
37 °C with heat-inactivated, uraemic plasma from
haemodialysis patients, the Mg2"4" efflux via Na*/Mg2*
antiport was increased from 0.25 ± 0.02 to 0.51 ±0.1;
Mg2*, mmol/30 min X l cells (mean ± SEM, n = 4,
p < 0.001). On the other hand, incubation of normal
erythrocytes for various periods up to 24 h with heat-
inactivated, uraemic plasma from haemodialysis patients
at extracellular Mg2"*" concentrations up to 4.5 mmol/1
(uraemic plasma with addition of 3 mmol/1 MgCl2) did
not affect the cellular Mg2"1" content (data not shown).
This result shows that in uraemic plasma no factor is
present which induces Mg2* uptake in erythrocytes.
Discussion
In chronic renal failure patient plasma, the Mg2* con-
centration was increased and almost normalised by
haemodialysis (tab. 3). The increase of erythrocyte
Mg2* is not caused by an altered activity of the Na"1"/
Mg^* antiporter, äs this System in human erythrocytes
is irreversible, leading only to net Mg2* efflux when the
cellular Mg2* coiitent is increased. Hence, Mg2* efflux
occurs in both erythrocytes from uraemic patients and
in Mg2*-loaded erythrocytes from controls (10).
Human erythröeytes do not take up Mg2* (11,12). Even
düring incubation with uraemic plasma at increased ex-
tracellular Mg2*, erythrocytes did not accumulate Mg2*,
therefore, the increased Mg?* concentration in uraemic
erythrocytes must be induced düring haematopoiesis. In
agreement with this conclusion, reticulocytes take up
Mg2* when incubated at an elevated extracellular Mg2*
concentration (6).
The difference in erythrocyte Mg2* content in haemodi-
alysis and chronic ambulatory peritoneal dialysis may
depend on the activity of Na*/Mg2* antiport. In haemo-
dialysis, the erythrocyte Mg2* content was lower and
the Na*/Mg2* antiport activity was higher than in
chronic ambulatory peritoneal dialysis. The Na*/Mg2*
antiport of normal erythrocytes was increased when they
were suspended in heat-inactivated plasma from haemo-
dialysis patients with a high Na*/Mg2* antiport. As the
method of determination of Na*/Mg2* antiport requires
plasma-free incubation of the erythrocytes for about 4
hours prior to measurement of transport rates, this effec-
tor must have a long lasting but reversible effect on the
Na*/Mg2* antiporter. Düring haemodialysis, this effec-
tor is at least partly removed, leading to reduced Na*/
Mg2* antiport capacity (tab. 3). In vivo, however, the
maximal transport capacity of Mg2*-loaded erythrocytes
is not attained and, therefore, only a small (and insignifi-
cant) reduction of total intracellular Mg2* content was
observed (tab. 3). Also, Na*/H* antiport, which has
similar properties to Na*/Mg2* antiport, was increased
in chronic renal failure patients (3). A dialysable, heat-
stable plasma constituent with a relative molecular mass
of A/r < 3000 from chronic renal failure patients has
been reported to inhibit Ca2* transport in normal eryth-
rocytes (5). This effector is not identified, but possible
candidates are interleukin-1, interleukin-6 and tumour
necrosis factor- . It has been reported that undialysed
patients with chronic renal failure and patients on
haemodialysis expressed increased plasma levels of
these cytokines (for references see I.e. (13)). Isolated
peripheral blood mononuclear cells from chronic ambu-
latory peritoneal dialysis patients produced less tumour
necrosis factor- than cells from haemodialysis patients
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(13). However, erythrocytes do not express receptors for
tumour necrosis factor-a (14). Therefore, it is not clear
whether these cytokines can directly cause the increase
of Na+/Mg2+ antiport.
An influence of urea (which accumulates to higher con-
centrations in patients receiving haemodialysis than in
those receiving chronic ambulatory peritoneal dialysis)
on the activity of Na+/Mg2+ antiport can be excluded.
In normal erythrocytes, urea concentrations up to 45
mmol/1 did not influence Na^/Mg24" antiport activity
(data not shown).
The elevated Na+/Mg2+ antiport in haemodialysis pa-
tients is also not caused by mechanic stress during
haemodialysis, because erythrocytes which were taken
immediately after the dialysis procedure even had re-
duced Na+/Mg2"1" antiport rates compared with those
taken before dialysis (tab. 3).
Increased formation of free oxygen radicals, which may
occur in erythrocytes of chronic renal failure patients
due to a reduction of protective enzymes (15), can also
be excluded. Free oxygen radicals have been shown to
decrease rather than increase Na+/Mg2* aritiport in hu-
man erythrocytes (16).
In chronic renal failure patients receivmg chronic ambu-
latory peritoneal dialysis, Na^/Mg2"1" antiport was not
changed. Probably, this procedure is more effective in
eliminating the activating plasma constituent
In all chronic renal failure patients after renal transplan-
tation, the quantities of Mg?+ metabolism were normal,
in parallel with the sufficient function of the trans-
planted kidney äs indicated by the plasma creatinine
concentration. As all transplant recipients were treated
with cyclosporin, one year after transplantätion, this
drug does not seem to have an influence on erythrocyte
Mg2+ metabolism.
It remains to be established whether cells other than
erythrocytes in haemodialysis patients show a high ac-
tivity of Na+TMg2* antiport. A generally increased ac-
tivity of Na^/Mg2* antiport in other cells might lead to
an intracellular Mg2"1" deficit.
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